0 items USD 0.00Search
Your search for "current partnering global royalty financing partnering terms agreements pharma biotech 0" gave back 1504912 results.
RNA-Targeted Novel Drug Modalities Based on RNA Editing, Epitranscriptomics, Direct RNA Targeting, Splicing Modulation, Translation Regulation,...
Catalog:
La Merie Publishing
November 2022
Price: USD 2,500.00
The Oncolytic Virus Landscape 2017: an analysis of pipeline, stakeholders, deals, industry trends & opportunities The field of oncolytic viruses...
Catalog:
La Merie Publishing
January 2017
Price: USD 2,400.00
Intracellular Targets made druggable by TCR-like Antibodies, TCR Fusion Proteins & Cell-Penetrating Biologics 2018: an industry analysis of...
Catalog:
La Merie Publishing
January 2018
Price: USD 2,800.00
This report provides a landscape description and analysis of chimeric antigen receptor-macrophage (CAR-M) platform technologies and stakeholders from...
Catalog:
La Merie Publishing
February 2023
Price: USD 2,000.00
Revenue-based financing, also defined as royalty-based financing, is a way of raising business capital from creditors, who earn a portion of a...
Catalog:
MRRPB5
May 2023
Price: USD 2,900.00
Revenue-based financing, also defined as royalty-based financing, is a way of raising business capital from creditors, who earn a portion of a...
Catalog:
LPI
March 2023
Price: USD 3,660.00
Vectorized Antibodies for In Vivo Expression by DNA and mRNA report provides you with a landscape description and analysis of direct in vivo delivery...
Catalog:
La Merie Publishing
July 2021
Price: USD 2,550.00
Revenue-based financing, also defined as royalty-based financing, is a way of raising business capital from creditors, who earn a portion of a...
Catalog:
MRRPB5
July 2023
Price: USD 4,900.00
A comparative analysis of the landscape of and business opportunities with TCR and CAR antibodies, T cells, NK cells, TILs, DLIs & CTLs The...
Catalog:
La Merie Publishing
March 2015
Price: USD 2,183.00
Non-alcoholic steatohepataitis (NASH) Pipeline Analysis” gives comprehensive insights on the various drugs being developed for the treatment of NASH...
Catalog:
IQ4I
February 2017
Price: USD 3,600.00
The report TCR & CAR Engineered T-Cell and NK Cell Therapeutics 2016: Convergence of technologies opens business opportunities beyond CD19 CARTs...
Catalog:
La Merie Publishing
June 2016
Price: USD 2,750.00
RNA-Targeted Small Molecules 2019: a landscape analysis of companies, technologies, targets, investors and partners from an industry perspective This...
Catalog:
La Merie Publishing
September 2019
Price: USD 2,350.00
The report entitled „Antibody-Drug Conjugates 2014 – A Business, Technology & Pipeline Analysis“ published in January 2014 is based on the...
Catalog:
La Merie Publishing
January 2014
Price: USD 2,298.00
Highlights The global Pharma and Biotech Clinical Stage Partnering Terms and Agreements Directory market was valued at US$ million in 2022 and is...
Catalog:
MRRPB5
May 2023
Price: USD 2,900.00
Market Analysis and Insights: Global Pharma and Biotech Clinical Stage Partnering Terms and Agreements Directory Market The global Pharma and Biotech...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
Filter By Report Date
Filter By Industry
Filter By Country
- (-) Remove Global filter Global
- Latin America (4) Apply Latin America filter
- Middle East (3) Apply Middle East filter
- Africa (2) Apply Africa filter
- America (1) Apply America filter
- Americas (1) Apply Americas filter
- Asia (1) Apply Asia filter
- BRIC (1) Apply BRIC filter
- Caribbean (1) Apply Caribbean filter
- Oceania (1) Apply Oceania filter
